KATP channel as well as SGLT1 participates in GIP secretion in the diabetic state

Journal of Endocrinology

Volumn 222, Issue 2, 2014, Pages 191-200

  Ogata, Hidetada ^a   Seino, Yusuke ^a   Harada, Norio ^b   Iida, Atsushi ^a   Suzuki, Kazuyo ^b   Izumoto, Takako ^a   Ishikawa, Kota ^a   Uenishi, Eita ^a   Ozaki, Nobuaki ^a,c   Hayashi, Yoshitaka ^c   Miki, Takashi ^d   Inagaki, Nobuya ^b   Tsunekawa, Shin ^a   Hamada, Yoji ^a   Seino, Susumu ^e   Oiso, Yutaka ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c NAGOYA UNIVERSITY   (Japan)

^d CHIBA UNIVERSITY   (Japan)

^e KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

GIP secretion; KATP channel; Sglt1

Indexed keywords

ADENOSINE TRIPHOSPHATE; DIAZOXIDE; GASTRIC INHIBITORY POLYPEPTIDE; GLIMEPIRIDE; GLUCOKINASE; GLUCOSE; PHLORIZIN; SODIUM GLUCOSE COTRANSPORTER 1; ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; INWARDLY RECTIFYING POTASSIUM CHANNEL; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR6.2; SLC5A1 PROTEIN, MOUSE; SULFONYLUREA DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; EPITHELIUM CELL; GLUCOSE ABSORPTION; IN VIVO STUDY; KILLER CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; ANIMAL; EXPERIMENTAL DIABETES MELLITUS; GIP SECRETION; PATHOPHYSIOLOGY; PHYSIOLOGY; SECRETION (PROCESS); SGLT1;

GIP SECRETION; KATP CHANNEL; SGLT1;

ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; DIAZOXIDE; GASTRIC INHIBITORY POLYPEPTIDE; GLUCOSE; KATP CHANNELS; MICE; PHLORHIZIN; POTASSIUM CHANNELS, INWARDLY RECTIFYING; SODIUM-GLUCOSE TRANSPORTER 1; SULFONYLUREA COMPOUNDS;

EID: 84905694169     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1530/JOE-14-0161     Document Type: Article

References (45)

1. Alvarado F & Crane RK 1962 Phlorizin as a competitive inhibitor of the active transport of sugars by hamster small intestine, in vitro. Biochimica et Biophysica Acta 56 170-172.
2. Baggio LL & Drucker DJ 2007 Biology of incretins: GLP-1 and GIP. Gastroenterology 132 2131-2157.
3. Breen DM, Rasmussen BA, Côté CD, Jackson VM& Lam TKT 2013 Nutrientsensing mechanisms in the gut as therapeutic targets for diabetes. Diabetes 62 3005-3013.
4. Brubaker PL 1991 Regulation of intestinal proglucagon-derived peptide secretion by intestinal regulatory peptides. Endocrinology 128 3175-3182.
5. Burant CF, Flink S, DePaoli AM, Chen J, Lee WS, Hediger MA, Buse JB & Chang EB 1994 Small intestine hexose transport in experimental diabetes. Increased transporter mRNA and protein expression in enterocytes. Journal of Clinical Investigation 93 578-585.
6. Cani PD, Holst JJ, Drucker DJ, Delzenne NM, Thorens B, Burcelin R & Knauf C 2007 GLUT2 and the incretin receptors are involved in glucose-induced incretin secretion. Molecular and Cellular Endocrinology 276 18-23.
7. Conarello SL, Jiang G,Mu J, Li Z,Woods J, Zycband E, Ronan J, Liu F, Roy RS, Zhu L et al. 2007 Glucagon receptor knockout mice are resistant to diet-induced obesity and streptozotocin-mediated b cell loss and hyperglycaemia. Diabetologia 50 142-150.
8. Damholt AB, Kofod H & Buchan AM 1999 Immunocytochemical evidence for a paracrine interaction between GIP and GLP-1-producing cells in canine small intestine. Cell and Tissue Research 298 287-293.
9. Diakogiannaki E, Gribble FM & Reimann F 2012 Nutrient detection by incretin hormone secreting cells. Physiology & Behavior 106 387-393.
10. Drucker DJ & NauckMA 2006 The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes. Lancet 368 1696-1705.
11. Egerod KL, Engelstoft MS, Grunddal KV, Nøhr MK, Secher A, Sakata I, Pedersen J, Windeløv JA, Füchtbauer E-M, Olsen J et al. 2012 A major lineage of enteroendocrine cells coexpress CCK, secretin, GIP, GLP-1, PYY, and neurotensin but not somatostatin. Endocrinology 153 5782-5795.
12. El-Ouaghlidi A, Rehring E, Holst JJ, Schweizer A, Foley J, Holmes D & Nauck MA 2007 The dipeptidyl peptidase 4 inhibitor vildagliptin does not accentuate glibenclamide-induced hypoglycemia but reduces glucoseinduced glucagon-like peptide 1 and gastric inhibitory polypeptide secretion. Journal of Clinical Endocrinology and Metabolism 92 4165-4171.
13. Ferraris RP, Villenas SA & Diamond J 1992 Regulation of brush-border enzyme activities and enterocyte migration rates in mouse small intestine. American Journal of Physiology 262 G1047-G1059.
14. Fujita Y, Kojima H, Hidaka H, Fujimiya M, Kashiwagi A & Kikkawa R 1998 Increased intestinal glucose absorption and postprandial hyperglycaemia at the early step of glucose intolerance in Otsuka Long-Evans Tokushima Fatty rats. Diabetologia 41 1459-1466.
15. Fujita Y, Wideman RD, Asadi A, Yang GK, Baker R, Webber T, Zhang T, Wang R, Ao Z, Warnock GL et al. 2010 Glucose-dependent insulinotropic polypeptide is expressed in pancreatic islet a-cells and promotes insulin secretion. Gastroenterology 138 1966-1975.
16. Fukami A, Seino Y, Ozaki N, Yamamoto M, Sugiyama C, Sakamoto-Miura E, Himeno T, Takagishi Y, Tsunekawa S, Ali S et al. 2012 Ectopic expression of GIP in pancreatic b-cells maintains enhanced insulin secretion in mice with complete absence of proglucagon-derived peptides. Diabetes 62 510-518.
17. Gorboulev V, Schürmann A, Vallon V, Kipp H, Jaschke A, Klessen D, Friedrich A, Scherneck S, Rieg T, Cunard R et al. 2012 NaC-D-glucose cotransporter SGLT1 is pivotal for intestinal glucose absorption and glucose-dependent incretin secretion. Diabetes 61 187-196.
18. Jang H, Kokrashvili Z, Theodorakis MJ, Carlson OD, Kim B-J, Zhou J, Kim HH, Xu X, Chan SL, Juhaszova M et al. 2007 Gut-expressed gustducin and taste receptors regulate secretion of glucagon-like peptide-1. PNAS 104 15069-15074.
19. Kellett GL 2001 The facilitated component of intestinal glucose absorption. Journal of Physiology 531 585-595.
20. Kim S-J, Nian C, Karunakaran S, Clee SM, Isales CM & McIntosh CHS 2012 GIP-overexpressing mice demonstrate reduced diet-induced obesity and steatosis, and improved glucose homeostasis. PLoS ONE 7 e40156.
21. Marti{dotless}́n MG, Turk E, Lostao MP, Kerner C& Wright EM 1996 Defects in NaC/ glucose cotransporter (SGLT1) trafficking and function cause glucose- galactose malabsorption. Nature Genetics 12 216-220.
22. McTaggart JS, Clark RH & Ashcroft FM 2010 The role of the KATP channel in glucose homeostasis in health and disease: more than meets the islet. Journal of Physiology 588 3201-3209.
23. Miki T, Nagashima K, Tashiro F, Kotake K, Yoshitomi H, Tamamoto A, Gonoi T, Iwanaga T, Miyazaki J & Seino S 1998 Defective insulin secretion and enhanced insulin action in KATP channel-deficient mice. PNAS 95 10402-10406.
24. Miki T, Minami K, Shinozaki H,Matsumura K, Saraya A, Ikeda H, Yamada Y, Holst JJ & Seino S 2005 Distinct effects of glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 on insulin secretion and gut motility. Diabetes 54 1056-1063.
25. Miyamoto K, Hase K, Takagi T, Fujii T, Taketani Y, Minami H, Oka T & Nakabou Y 1993 Differential responses of intestinal glucose transporter mRNA transcripts to levels of dietary sugars. Biochemical Journal 295 211-215.
26. Moriya R, Shirakura T, Ito J, Mashiko S & Seo T 2009 Activation of sodiumglucose cotransporter 1 ameliorates hyperglycemia by mediating incretin secretion in mice. American Journal of Physiology. Endocrinology and Metabolism 297 E1358-E1365.
27. Nauck MA, Heimesaat MM, Orskov C, Holst JJ, Ebert R & Creutzfeldt W 1993 Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus. Journal of Clinical Investigation 91 301-307.
28. Parker HE, Habib AM, Rogers GJ, Gribble FM & Reimann F 2009 Nutrientdependent secretion of glucose-dependent insulinotropic polypeptide from primary murine K cells. Diabetologia 52 289-298.
29. Pearson ER, Flechtner I, Njølstad PR, Malecki MT, Flanagan SE, Larkin B, Ashcroft FM, Klimes I, Codner E, Iotova V et al. 2006 Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations. New England Journal of Medicine 355 467-477.
30. Polak JM, Bloom SR, Kuzio M, Brown JC & Pearse AG 1973 Cellular localization of gastric inhibitory polypeptide in the duodenum and jejunum. Gut 14 284-288.
31. Powell DR, Smith M, Greer J, Harris A, Zhao S, Da Costa C, Mseeh F, Shadoan MK, Sands A, Zambrowicz B et al. 2013 LX4211 increases serum glucagon-like peptide 1 and peptide YY levels by reducing sodium/glucose cotransporter 1 (SGLT1)-mediated absorption of intestinal glucose. Journal of Pharmacology and Experimental Therapeutics 345 250-259.
32. Rocca AS & Brubaker PL 1999 Role of the vagus nerve in mediating proximal nutrient-induced glucagon-like peptide-1 secretion. Endocrinology 140 1687-1694.
33. Sakamoto E, Seino Y, Fukami A, Mizutani N, Tsunekawa S, Ishikawa K, Ogata H, Uenishi E, Kamiya H, Hamada Y et al. 2012 Ingestion of a moderate high-sucrose diet results in glucose intolerance with reduced liver glucokinase activity and impaired glucagon-like peptide-1 secretion. Journal of Diabetes Investigation 3 432-440.
34. Seino Y, Miki T, Kiyonari H, Abe T, Fujimoto W, Kimura K, Takeuchi A, Takahashi Y, Oiso Y, Iwanaga T et al. 2008 Isx participates in the maintenance of vitamin A metabolism by regulation of b-carotene 15,150-monooxygenase (Bcmo1) expression. Journal of Biological Chemistry 283 4905-4911.
35. Seino Y, Fukushima M & Yabe D 2010 GIP and GLP-1, the two incretin hormones: similarities and differences. Journal of Diabetes Investigation 1 8-23.
36. Seino S, Shibasaki T & Minami K 2011 Dynamics of insulin secretion and the clinical implications for obesity and diabetes. Journal of Clinical Investigation 121 2118-2125.
37. Seino Y, Miki T, Fujimoto W, Young-Lee E, Takahashi Y, Minami K, Oiso Y & Seino S 2013 Cephalic phase insulin secretion is KATP channel independent. Journal of Endocrinology 218 25-33.
38. Stephens JW, Bodvarsdottir TB, Wareham K, Prior SL, Bracken RM, Lowe GD, Rumley A, Dunseath G, Luzio S, Deacon CF et al. 2011 Effects of short-term therapy with glibenclamide and repaglinide on incretin hormones and oxidative damage associated with postprandial hyperglycaemia in people with type 2 diabetes mellitus. Diabetes Research and Clinical Practice 94 199-206.
39. Sykes S, Morgan LM, English J & Marks V 1980 Evidence for preferential stimulation of gastric inhibitory polypeptide secretion in the rat by actively transported carbohydrates and their analogues. Journal of Endocrinology 85 201-207.
40. Takata K, Kasahara T, Kasahara M, Ezaki O & Hirano H 1992 Immunohistochemical localization of NaC-dependent glucose transporter in rat jejunum. Cell and Tissue Research 267 3-9.
41. Thomas FB, Shook DF, O'Dorisio TM, Cataland S, Mekhjian HS, Caldwell JH & Mazzaferri EL 1977 Localization of gastric inhibitory polypeptide release by intestinal glucose perfusion in man. Gastroenterology 72 49-54.
42. Woerle HJ, Carneiro L, Derani A, Göke B & Schirra J 2012 The role of endogenous incretin secretion as amplifier of glucose-stimulated insulin secretion in healthy subjects and patients with type 2 diabetes. Diabetes 61 2349-2358.
43. Wright EM 1998 I. Glucose galactose malabsorption. American Journal of Physiology 275 G879-G882.
44. Yabe D, Kuroe A, Lee S, Watanabe K, Hyo T, Hishizawa M, Kurose T, Deacon CF, Holst JJ, Hirano T et al. 2010 Little enhancement of meal-induced glucagon-like peptide 1 secretion in Japanese: comparison of type 2 diabetes patients and healthy controls. Journal of Diabetes Investigation 1 56-59.
45. Yoshikawa T, Inoue R, Matsumoto M, Yajima T, Ushida K & Iwanaga T 2011 Comparative expression of hexose transporters (SGLT1, GLUT1, GLUT2 and GLUT5) throughout the mouse gastrointestinal tract. Histochemistry and Cell Biology 135 183-194.